SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICOS Corporation

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: limit who wrote (704)5/20/1999 7:50:00 PM
From: Edscharp  Read Replies (1) of 1139
 
I appreciate the article. Believe it or not I am familiar with their pipeline. I will repeat for the last time. It is a good company with a promising pipeline and strong management, but they are also over-valued. Leukarrest is at least two years away from marketing.

My experience with other biotech stocks is that the typical investor gets bored with a stock that produces no revenues and has no projected revenues in the imminent future. There are other drug companies with pipelines as good as ICOS and they have not gone up in value. Check Isis Pharmacy (ISIP) or Ligand (LGND). ICOS does however have one thing these companies don't, Bill Gates.

To answer the question of a previous poster. I am not short ICOS. I have never shorted a stock and likely never will.

ICOS is on my watch list. If the valuation ever improves I will seriously consider purchasing it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext